Does Risperdal Cause Gynecomastia?
Yes, Risperdal (risperidone) can cause gynecomastia, which is the enlargement of breast tissue in males due to elevated prolactin levels. Risperidone blocks dopamine D2 receptors, leading to hyperprolactinemia—a known side effect that disrupts hormone balance and promotes breast tissue growth.[1][2]
How Common Is Gynecomastia with Risperdal?
Gynecomastia occurs in 0.5-1% of male patients on risperidone in clinical trials, but real-world reports suggest higher rates, especially with long-term use or higher doses. The risk rises with duration: short-term use (under 6 months) shows low incidence, while chronic treatment correlates with up to 10% in some adolescent studies.[3][4]
Why Does Risperdal Raise Prolactin More Than Other Antipsychotics?
Risperidone has stronger prolactin-elevating effects than atypicals like aripiprazole or quetiapine because its affinity for D2 receptors persists longer in the pituitary gland. Paliperidone, its active metabolite, behaves similarly. First-generation antipsychotics like haloperidol also elevate prolactin, but risperidone's profile stands out among second-generation drugs.[1][5]
What Do Patients Report About Gynecomastia?
User forums and adverse event databases like FAERS log thousands of gynecomastia cases linked to risperidone, often describing painful, persistent breast swelling starting months into treatment. Adolescents and young males report higher rates, with some cases requiring surgery. Symptoms may persist after stopping the drug.[2][6]
Can Gynecomastia from Risperdal Be Reversed?
It often reverses after dose reduction, switching to a prolactin-sparing antipsychotic (e.g., aripiprazole), or discontinuation, but reversibility varies—up to 30% of cases remain permanent if untreated early. Monitoring prolactin levels and breast exams helps catch it early.[3][4]
Legal Cases and Manufacturer Warnings
Johnson & Johnson faced lawsuits over Risperdal-induced gynecomastia, with settlements exceeding $2 billion for failure to warn about risks, especially in children. The label now lists gynecomastia and hyperprolactinemia as warnings, advising baseline prolactin checks.[7]
Alternatives for Patients Worried About This Risk
Switch to low-prolactin antipsychotics like aripiprazole (Abilify) or olanzapine (Zyprexa), which rarely cause gynecomastia. Clozapine is another option for refractory cases. Doctors weigh this against efficacy for schizophrenia or bipolar disorder.[5]
[1]: FDA Risperdal Label
[2]: PubMed: Risperidone and Gynecomastia Review
[3]: JAMA Psychiatry: Prolactin Elevation with Antipsychotics
[4]: American Journal of Psychiatry: Adolescent Gynecomastia Risk
[5]: DrugPatentWatch: Risperdal Patent Info (notes related litigation on side effects)
[6]: FDA FAERS Database Search: Risperidone + Gynecomastia
[7]: Reuters: Risperdal Gynecomastia Settlements